Art

J-GLOBAL ID：202002223680497737   Reference number：20A0560453

水疱をどう診る?どう治す?自己免疫性水疱症を治療する際の注意点

Author (1)： TANIKAWA AKIKO (慶応大 医 皮膚科学)
Material： Monthly Book Derma.  (MB Derma)
Issue： 292  Page： 53-61  Publication year： Feb. 15, 2020 
JST Material Number： L3871A  ISSN： 1343-0831  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *autoimmune disease ,...
Semi thesaurus term： *Auto-immune bullosis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0560453&from=J-GLOBAL&jstjournalNo=L3871A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for skin diseases  (GF05020A)

Reference (14)：

• Cain DW, Cidlowski JA :Immune regulation by glucocorticoids. Nat Rev Immunol, 17 :233-247, 2017.
• Suzuki Y, Nawata H, Soen S, et al :Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research : 2014 update. J Bone Miner Metab, 32 : doi : 10.1007/s00774-014-0586-6, 2014.
• 宗圓 聰:ステロイド性骨粗鬆症を防ぐには.日本医事新報, 4949:34-39,2019.
• Grossman JM, Gordon R, Ranganath VK, et al: American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res, 62 : 1515-1526,2010.
• Van Staa TP, Laan RF, Barton IP, et al : Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum, 48 : 3224-3229, 2003.

Terms in the title (4)： 水疱 ,  自己免疫性水疱症 ,  治療 ,  注意